Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Human Staphylococcus aureus polyclonal immunoglobulin and human Staphylococcus epidermidis polyclonal immunoglobulin

EU orphan designation number: EU/3/05/335
Active ingredient: Human Staphylococcus aureus polyclonal immunoglobulin and human Staphylococcus epidermidis polyclonal immunoglobulin
Indication: Prevention of late onset sepsis in premature infants of less or equal than 32 weeks gestational age
Sponsor: Omnicare Clinical Research
Wessex Business Centre, Bumpers Way, Bumpers Farm, Chippenham, Wiltshire SN14 6NQ, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/12/2005 Orphan Designation EMEA/OD/059/05 (2005)5625 of 14/12/2005
05/03/2008 Removal of orphan designation from Community Register